La Jolla Pharma’s drug improves kidney function in trial

(Reuters) – La Jolla Pharmaceutical Co said its experimental drug to treat chronic kidney disease met the main goal of improving kidney function in a mid-stage study, sending the company’s shares up…

    

Leave a Reply

Your email address will not be published.